» Articles » PMID: 16433914

Patterns of Drug Use Among a Sample of Drug Users and Injecting Drug Users Attending a General Practice in Iran

Overview
Journal Harm Reduct J
Publisher Biomed Central
Specialties Pharmacology
Psychiatry
Date 2006 Jan 26
PMID 16433914
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study aimed to examine drug use, drug treatment history and risk behaviour among a sample of Iranian drug users seeking treatment through a general practice clinic in Iran.

Methods: Review of medical records and an intake questionnaire at a large general practice in Marvdasht, Iran, with a special interest in drug dependence treatment. Records from a random sample of injecting drug users (IDU), non-injecting drug users (DU) and non-drug using patients were examined.

Results: 292 records were reviewed (34% IDU, 31% DU and 35% non-drug users). Eighty-three percent were males; all females were non-drug users. The mean age of the sample was 30 years. Of the IDU sample, 67% reported sharing a needle or syringe, 19% of these had done so in prison. Of those who had ever used drugs, being 'tired' of drug use was the most common reason for seeking help (34%). Mean age of first drug use was 20 years. The first drugs most commonly used were opium (72%), heroin (13%) and hashish/ other cannabinoids (13%). Three quarters reported having previously attempted to cease their drug use. IDU were more likely than DU to report having ever been imprisoned (41% vs 7%) and 41% to have used drugs in prison.

Conclusion: This study has shown that there is a need for general practice clinics in Iran to treat drug users including those who inject and that a substantial proportion of those who inject have shared needles and syringes, placing them at risk of BBVI such as HIV and hepatitis C. The expansion of services for drug users in Iran such as needle and syringe programs and pharmacotherapies are likely to be effective in reducing the harms associated with opium use and heroin injection.

Citing Articles

Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.

Mirzazadeh A, Hosseini-Hooshyar S, Shahesmaeili A, Bahramnejad A, Barshan A, Mousavian G Subst Abuse Treat Prev Policy. 2020; 15(1):56.

PMID: 32758246 PMC: 7405425. DOI: 10.1186/s13011-020-00298-y.


The impact of motivational interviewing on relapse to substance use among women in Iran: a randomized clinical trial.

Oveisi S, Stein L, Babaeepour E, Araban M BMC Psychiatry. 2020; 20(1):157.

PMID: 32272923 PMC: 7147038. DOI: 10.1186/s12888-020-02561-9.


Analysis of Mortality Rate of Illicit Substance Abuse and its Trend in Five Years in Iran, 2014-2018.

Shahbazi F, Mirtorabi D, Ghadirzadeh M, Hashemi-Nazari S Addict Health. 2019; 10(4):260-268.

PMID: 31263525 PMC: 6593170. DOI: 10.22122/ahj.v10i4.602.


Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.

Noroozi M, Noroozi A, Sharifi H, Ghaedamini Harouni G, Marshall B, Ghisvand H Int J Behav Med. 2018; 26(1):50-58.

PMID: 30460445 DOI: 10.1007/s12529-018-9758-4.


Bayesian Zero- Inflated Poisson model for prognosis of demographic factors associated with using crystal meth in Tehran population.

Pourhoseingholi A, Baghestani A, Ghasemi E, Baghban A, Ghazarian M Med J Islam Repub Iran. 2018; 32:24.

PMID: 30159275 PMC: 6108249. DOI: 10.14196/mjiri.32.24.


References
1.
Barnard M . Needle sharing in context: patterns of sharing among men and women injectors and HIV risks. Addiction. 1993; 88(6):805-12. DOI: 10.1111/j.1360-0443.1993.tb02094.x. View

2.
Suligoi B, Magliochetti N, Nicoletti G, Pezzotti P, Rezza G . Trends in HIV prevalence among drug-users attending public drug-treatment centres in Italy: 1990-2000. J Med Virol. 2004; 73(1):1-6. DOI: 10.1002/jmv.20054. View

3.
Swift W, Copeland J . Treatment needs and experiences of Australian women with alcohol and other drug problems. Drug Alcohol Depend. 1996; 40(3):211-9. DOI: 10.1016/0376-8716(95)01209-5. View

4.
Brown T, Topp J, Ross D . Rationales, obstacles and strategies for local outcome monitoring systems in substance abuse treatment settings. J Subst Abuse Treat. 2003; 24(1):31-42. DOI: 10.1016/s0740-5472(02)00342-2. View

5.
Dolan K . Can hepatitis C transmission be reduced in Australian prisons?. Med J Aust. 2001; 174(8):378-9. DOI: 10.5694/j.1326-5377.2001.tb143335.x. View